Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

Half-year report 31 December 2013

21 February 2014 by Justine Bednorz

Half-year report 31 December 2013

Categories 2014, ASX Announcements, Half-year reports

Key USA Patent allowed for Biotron’s BIT225

BIT225 HIV/HCV Trial Patients Virus Free at Six Months

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 6 September 2024 Legal Notices and Privacy